Vincent Hennemand discusses using these types of therapies to develop treatments for autoimmune conditions.
Vincent Hennemand
Advertisement
Articles by Vincent Hennemand
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Viatris Acquires Pacira BioSciences for $1.65 Billion
2
Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
3
FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Metastatic Breast Cancer
4
ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care
5